-+ 0.00%
-+ 0.00%
-+ 0.00%
3 Asian Growth Stocks With Strong Insider Ownership
Share
Listen to the news

Amidst a backdrop of economic uncertainties and fluctuating market conditions in Asia, investors are increasingly turning their attention to growth companies with strong insider ownership. In this environment, stocks that demonstrate robust internal confidence can offer an appealing prospect for those seeking stability and potential growth.

Top 10 Growth Companies With High Insider Ownership In Asia

Name Insider Ownership Earnings Growth
Suzhou Dongshan Precision Manufacturing (SZSE:002384) 33.5% 72%
Shanghai Biren Technology (SEHK:6082) 10.4% 118.4%
Seojin SystemLtd (KOSDAQ:A178320) 18% 110.8%
SEERS (KOSDAQ:A458870) 33.8% 39.7%
Ningbo Sanxing Medical ElectricLtd (SHSE:601567) 24.9% 45.6%
Meitu (SEHK:1357) 22.8% 31.3%
Meiko Electronics (TSE:6787) 19.2% 30.1%
Gold Circuit Electronics (TWSE:2368) 29.8% 42.6%
Fulin Precision (SZSE:300432) 11.2% 60.7%
Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) 14.1% 41%

Click here to see the full list of 498 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Here we highlight a subset of our preferred stocks from the screener.

Gpixel Changchun Microelectronics (SEHK:3277)

Simply Wall St Growth Rating: ★★★★★★

Overview: Gpixel Changchun Microelectronics Inc. designs and supplies customized and off-the-shelf CMOS image sensor solutions, with a market cap of HK$24.06 billion.

Operations: The company's revenue is primarily derived from its Semiconductors segment, totaling CN¥1.14 billion.

Insider Ownership: 18.2%

Return On Equity Forecast: 24% (2029 estimate)

Gpixel Changchun Microelectronics has demonstrated impressive growth, with recent earnings more than doubling to CNY 250.23 million for the first half of 2026. The company's revenue is forecasted to grow at an annual rate of 28.1%, surpassing market expectations. Insider ownership remains high, supporting shareholder alignment, while no significant insider trading activity has been reported recently. Despite a volatile share price, it trades below estimated fair value and benefits from strong demand in industrial imaging applications.

SEHK:3277 Earnings and Revenue Growth as at Aug 2026
SEHK:3277 Earnings and Revenue Growth as at Aug 2026

Akeso (SEHK:9926)

Simply Wall St Growth Rating: ★★★★★★

Overview: Akeso, Inc. is a biopharmaceutical company focused on the research, development, manufacture, and commercialization of antibody drugs globally with a market cap of HK$86.77 billion.

Operations: The company's revenue primarily comes from the research, development, production, and sale of biopharmaceutical products, amounting to CN¥3.06 billion.

Insider Ownership: 18.2%

Return On Equity Forecast: 20% (2028 estimate)

Akeso, Inc. is advancing rapidly with substantial insider ownership and a robust pipeline of innovative oncology treatments. Recent positive Phase III trial results for ivonescimab in advanced biliary tract cancer underscore its potential as a groundbreaking therapy. The company forecasts revenue growth of 28.6% annually, outpacing the market, while insiders have been actively buying shares recently. Akeso's focus on bispecific antibodies and next-generation ADCs positions it well for continued growth in the competitive biopharmaceutical sector.

SEHK:9926 Ownership Breakdown as at Aug 2026
SEHK:9926 Ownership Breakdown as at Aug 2026

Semight Instruments (SHSE:688808)

Simply Wall St Growth Rating: ★★★★★★

Overview: Semight Instruments Co., Ltd. develops and supplies test and measurement instruments and equipment in China and internationally, with a market cap of CN¥231.92 billion.

Operations: Semight Instruments generates revenue from its development and supply of test and measurement instruments and equipment both domestically in China and internationally.

Insider Ownership: 27.5%

Return On Equity Forecast: 61% (2029 estimate)

Semight Instruments is poised for significant growth, with revenue expected to increase by 62.3% annually, outpacing the broader Chinese market. The company's earnings are set to grow substantially at 74.82% per year, surpassing market averages. Despite a highly volatile share price recently and high non-cash earnings, Semight's forecasted return on equity remains robust at 61.1%. No recent insider trading activity has been reported over the past three months.

SHSE:688808 Ownership Breakdown as at Aug 2026
SHSE:688808 Ownership Breakdown as at Aug 2026

Turning Ideas Into Actions

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending